Tardive dyskinesia induced by risperidone? 1996

M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane

UI MeSH Term Description Entries
D008297 Male Males
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D018967 Risperidone A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. R-64,766,R-64766,Risperdal Consta,Risperidal,Consta, Risperdal,R 64,766,R 64766,R64,766,R64766

Related Publications

M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
May 1996, The American journal of psychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
August 1999, The American journal of psychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
January 1998, The Journal of clinical psychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
July 2000, Pharmacopsychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
March 1998, Pharmacopsychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
January 1997, Movement disorders : official journal of the Movement Disorder Society,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
October 2002, Indian journal of psychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
November 2001, The American journal of psychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
November 1996, Journal of the American Academy of Child and Adolescent Psychiatry,
M G Woerner, and B B Sheitman, and J A Lieberman, and J M Kane
May 2001, International journal of geriatric psychiatry,
Copied contents to your clipboard!